Status:
UNKNOWN
Ethnic Differences and the Ischemia/Bleeding Risk of DAPT Duration
Lead Sponsor:
Seoul National University Hospital
Conditions:
Coronary Artery Disease
Percutaneous Coronary Intervention
Eligibility:
All Genders
19-100 years
Brief Summary
this study is an individual patient level meta-analysis of randomized clinical trials, to evaluate the influence of ethnicity, to study whether the relative tradeoff between ischemia and bleeding is d...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- patients enrolled in previous RCTs related to the duration of dural antiplatelet agent therapy
Exclusion
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2018
Estimated Enrollment :
16000 Patients enrolled
Trial Details
Trial ID
NCT03338335
Start Date
March 1 2017
End Date
October 31 2018
Last Update
February 22 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-744